DXP Enterprises (DXPE) concentration risks

The company's disclosed concentration profile is limited to a single supply-side dependency. The company holds distribution rights for certain product lines and depends on those rights for a substantial portion of its business, a moderate-share exposure by disclosed size with a dependency character. Distribution agreements with key suppliers are the mechanism through which the company accesses and resells its product portfolio, and the continuation of those rights — on acceptable terms, at appropriate pricing, and without competitive encroachment — is a prerequisite for sustaining the existing revenue base. The dependency character indicates this is an idiosyncratic rather than structural risk: the exposure is not a broad market feature but rather a function of specific contractual arrangements with named suppliers whose decisions to renew, renegotiate, or terminate distribution rights could directly affect a meaningful portion of operations. A supplier that elects to go direct-to-market, awards distribution to a competitor, or imposes materially worse terms at renewal would reduce the company's addressable market in the affected product lines. No customer or geographic concentrations are separately disclosed, which suggests the revenue base across the customer side is reasonably diversified at a level below disclosure thresholds. On balance, the primary watchpoint is the continuity and terms of distribution agreements with key suppliers. Investors should monitor contract renewal timelines and any disclosed changes in supplier go-to-market strategy as the most important idiosyncratic risk variables in this profile.

For the engine’s reasoning on DXPE’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.